Imperial College London
Portrait Picture

MrAlexLiddle

Faculty of Medicine, Department of Surgery & Cancer

Clinical Senior Lecturer in Orthopaedics
 
 
 
//

Contact

 

a.liddle Website

 
 
//

Assistant

 

Miss Colinette Hazel +44 (0)20 7594 2725

 
//

Location

 

203Sir Michael Uren HubWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Carlos:2017:10.1080/21678707.2017.1279050,
author = {Carlos, Rodriguez-Merchan E and Liddle, AD},
doi = {10.1080/21678707.2017.1279050},
journal = {Expert opinion on orphan drugs},
pages = {173--179},
title = {Pathogenesis and treatment options for hemophilic synovitis},
url = {http://dx.doi.org/10.1080/21678707.2017.1279050},
volume = {5},
year = {2017}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Introduction: Hemophilia is characterized by recurrent bleeding episodes, most commonly in the knees, elbows and ankles. Repeated hemarthroses lead to synovial hypertrophy and a vicious cycle of chronic synovitis arises, leading to destruction of the joint.Areas covered: This article covers the pathogenesis of chronic hemophilic synovitis and its treatment by means of different types of synovectomy.Expert opinion: Both radiosynovectomy (RS) and arthroscopic synovectomy considerably improve the frequency of bleeding episodes. RS is the best option for patients with synovitis unresponsive to a three-month trial of hematological prophylaxis. If the bleeding is refractory to three successive episodes of RS at six monthly intervals, arthroscopic synovectomy is indicated. Open synovectomy should be reserved for adults with elbow synovitis requiring radial head removal and synovectomy in the same surgical session. RS is effective and safe, and particularly helpful in patients with inhibitors as they are at greatest risk of bleeding episodes and have the highest risk of complications of surgery.
AU  - Carlos,Rodriguez-Merchan E
AU  - Liddle,AD
DO  - 10.1080/21678707.2017.1279050
EP  - 179
PY  - 2017///
SN  - 2167-8707
SP  - 173
TI  - Pathogenesis and treatment options for hemophilic synovitis
T2  - Expert opinion on orphan drugs
UR  - http://dx.doi.org/10.1080/21678707.2017.1279050
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394437600008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - http://hdl.handle.net/10044/1/70374
VL  - 5
ER  -
Download